Showing results (1-10 of 248) with videos related to
Sort By:
Pageof 25
Pediatric Clinics of North America|December 2, 2014
Neuroblastoma: paradigm for precision medicineMeredith S Irwin, Julie R ParkJCO Clinical Cancer Informatics|January 18, 2019
Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification SystemArlene Naranjo, Meredith S Irwin, Michael D Hogarty, et al.Cell Cycle (Georgetown, Tex.)|January 24, 2004
Family feud in chemosensitvity: p73 and mutant p53Meredith S IrwinPediatric Blood & Cancer|July 17, 2023
Children's Oncology Group's 2023 blueprint for research: NeuroblastomaRochelle Bagatell, Steven G DuBois, Arlene Naranjo, et al.Oncotarget|August 12, 2014
Spy'ing on differentiation in neuroblastomaMonika Podkowa, Meredith S IrwinJournal of the National Comprehensive Cancer Network : JNCCN|August 16, 2024
Current and Emerging Biomarkers: Impact on Risk Stratification for NeuroblastomaMeredith S Irwin, Kelly C GoldsmithNeoplasia (New York, N.Y.)|August 24, 2006
Ubiquitin and ubiquitin-like modifications of the p53 familyIan R Watson, Meredith S IrwinEuropean Journal of Cancer (Oxford, England : 1990)|June 4, 2020
Association of heterogeneous MYCN amplification with clinical features, biological characteristics and outcomes in neuroblastoma: A report from the Children's Oncology GroupKevin Campbell, Arlene Naranjo, Emily Hibbitts, et al.Cancer Cell|February 15, 2011
NEDD8 pathways in cancer, Sine Quibus NonIan R Watson, Meredith S Irwin, Michael OhhAmerican Journal of Ophthalmology|February 2, 2020
Incidence and Prognostic Role of the Ocular Manifestations of Neuroblastoma in ChildrenSybille Graef, Meredith S Irwin, Michael J WanPageof 25